PICO Advisory Sub-Committee - Applications Considered
- 1420: Extracoporeal photopheresis for treatment of acute and chronic graft-versus-host disease and cutaneousT-cell lymphoma
- 1429: Targeted Intraoperative Radiotherapy for Early-Stage Breast Cancer
- 1431: HbA1c point of care testing for the diagnosis and management of diabetes mellitus
- 1435: Processing of gonadal tissue and gametes
- 1439: Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis
- 1440: PD-L1 testing for access to pembrolizumab in treatment naïve patients with locally advanced or metastatic non-small cell lung cancer
- 1443: Implantable loop recorders for diagnosis of atrial fibrillation in cryptogenic stroke
- 1445: PD-L1 (Programmed Death 1 Ligand) immunohistochemistry testing for access to pembrolizumab in patients with recurrent or progressive metastatic or locally advanced/unresectable bladder cancer that has recurred or progressed following platinum-based chemotherapy
- 1434: Anti-Müllerian hormone testing
- 1356: Melanoma surveillance photography – total body photography and digital dermoscopy